GermQToward Superbug-Free Societies

About GermQ

GermQ — Toward Superbug-Free Societies

GermQ is a visual concept for connecting surveillance, research, clinical context, policy and public awareness across a regional AMR ecosystem.

GermQ

Clinical Intelligence & Precision Care

Patient context, laboratory evidence and stewardship review.

AMR Data & Predictive Intelligence

Transparent simulated analysis of connected resistance signals.

One Health & Biosecurity

Human, animal, agricultural and environmental perspectives.

Surveillance, GIS & Early Warning

Geographic signals connected to trends and alert investigation.

Current stage: interactive concept. Built for healthcare providers, researchers, hospital administrators and public-health teams. No operational AI, institutional integrations, validated clinical performance or measured GermQ outcomes are claimed.

Mission

Turn fragmented AMR data into trusted intelligence that supports coordinated action.

Vision

Toward Superbug-Free Societies, beginning in Saudi Arabia with global scalability as an ambition.

Goals

Strengthen surveillance, accelerate research, support stewardship and build public capability.

Values

Scientific integrity, collaboration, inclusion, responsibility and public benefit.

AEIEI

A continuous intelligence cycle

Acquire → Explore → Interpret → Engage → Improve. The concept connects diverse signals, makes patterns visible, supports expert interpretation, shares findings with stakeholders and feeds action back into surveillance.

1. Acquire2. Explore3. Interpret4. Engage5. Improve
Governance overview

Stewardship council

Sets priorities and safeguards public value.

Scientific advisory group

Reviews methods, evidence and interpretation.

Partner forum

Connects sectors and participating organisations.

Code of conduct

GermQ's concept is grounded in responsible evidence use, respect for privacy, transparent interpretation, non-discrimination, scientific independence and clear separation between decision support and professional judgement.

Programme record

Saudi Antibiotics Integrated Regulatory Program (SAIR)

Launched in October 2016.

Aim

To address antimicrobial resistance within an approachable national and international programme, halting antimicrobial misuse in the community through awareness, public policies, epidemiological surveillance and unique solutions.

Vision

To provide a global reference in health and community prevention, where SAIR is a pioneering model in sustainable development through optimal and innovative health applications.

Mission

Empowering a promising national and global programme that unites efforts between health and educational institutions, with ubiquitous solutions related to generative AI.

Core values

Accountable, responsible and collaborative — working with integrity and innovation alongside local and international agencies to build an antimicrobial-resistance-free society with efficient public stewards.

Objectives

  1. 1Improving the healthcare system through advancing surveillance and development across the MENA region, starting with the Kingdom of Saudi Arabia.
  2. 2Improving health practice and unifying the efforts of health and educational institutions in alignment with the Sustainable Development Goals.
  3. 3Educating community members and healthcare providers about antimicrobial resistance.
  4. 4Leading civic engagements and awareness campaigns.
  5. 5Enriching health content by translating scientific articles and publications into more accessible and appealing formats.
  6. 6Promoting research and conducting qualitative surveillance analysis across the MENA region.
  7. 7Empowering youth and women through development and volunteering.

Programme divisions

Community-based section

Health literacy for community members through on-site and virtual campaigns, brochures, infographics and animated and documentary videos.

Research-based section

Quantitative and qualitative research to measure resistance and reduce disease burden, with MOH, MEWA, SFDA, KAIMRC, NGHA and government, private and civil-society partners.

University-based section

Enriching higher education and academic skills, from microbiology fundamentals to stewardship and genomics teaching.

Phase I: Raising awareness among community members and healthcare providers about antimicrobial resistance.

Phase II: Assisting decision and policy makers to set regulation for antimicrobial dispensing.

Who the programme serves

Community members

Almost 50% of the Saudi population believes antibiotics can treat viral infections (Saudi FDA report).

Healthcare providers

Infection prevention, stewardship and surveillance insight across multidisciplinary specialties.

Health agencies

Regulation, policy making and integrated national response.

Livestock owners

Antimicrobial use in animals and food systems.

Health-related students

Students, interns and residents building early AMR capability.

Sustainable Development Goals

SDG 2

Zero hunger

Antimicrobial use in food production and foodborne resistance.

SDG 3

Good health and well-being

Reducing morbidity, mortality and the burden of resistant infection.

SDG 4

Quality education

Professional education, clinical training and curriculum development.

SDG 6

Clean water and sanitation

Water, wastewater and environmental transmission pathways.

SDG 8

Decent work and economic growth

Protecting productivity and reducing economic loss from resistance.

SDG 12

Responsible consumption

Responsible antimicrobial consumption and stewardship.

SDG 16

Peace, justice and strong institutions

Governance, regulation and accountable institutions.

SDG 17

Partnerships for the goals

Uniting health, educational, government and civil-society partners.

Historical programme collaborating entities

Ministry of Health (MOH)National Guard Health Affairs (NGHA)Ministry of Environment, Water and Agriculture (MEWA)Saudi Food and Drug Authority (SFDA)Saudi Commission for Health Specialties (SCFHS)King Abdullah International Medical Research Center (KAIMRC)King Saud bin Abdulaziz University for Health Sciences (KSAU-HS)Imam Abdulrahman bin Faisal University (IAU)King Fahad Medical City (KFMC)Prince Sultan Cardiac Center (PSC)Riyadh's Second Health Cluster (RC2)World Health Organization and WFUNA Global Model WHO

Intended impact

Theory of Change

A proposed pathway, not measured GermQ health outcomes.

  1. 01

    Inputs

    Future institutional data, scientific evidence and sector expertise.

  2. 02

    Activities

    Connect signals, interpret patterns and support professional review.

  3. 03

    Outputs

    Intelligence views, alerts, case context and coordinated reports.

  4. 04

    Potential Outcomes

    More timely investigation, continuity of care and stewardship.

  5. 05

    Intended Long-Term Impact

    Toward Superbug-Free Societies. Outcomes require future validation.

Technology & future integrations

Explore roadmap

Current concept

Local illustrative data, interactive charts, GIS, role switching and scripted intelligence.

Planned AI & analysis

Python, SVM, Logistic Regression, OCR and NLP — not operational models.

Planned interoperability

HL7 FHIR, EHR/EMR, LIS and institutional APIs — no live integrations.

Future security & validation

Institutional governance, access controls, clinical evaluation and external validation before deployment.

Mohammed Alaqil

Research & Project Lead

Responsible innovation: future institutional governance, clinical evaluation and external validation are required before real-world use.